Leaflet MYOVIEW 230mcg kit for radiopharmaceutical preparations

Indicated for: myocardial perfusion imaging

Route of administration: injectable

Substance: Tc - tetrofosmin (contrast agent)

ATC: V09GA02 (Various | Cardiovascular system | Technetium (99mtc) compounds)

Precautions:
Anaphylaxis
Anaphylaxis

Risk of severe allergic reaction. Seek urgent medical help if serious symptoms occur.

Additional monitoring
Additional monitoring

This medicine is subject to additional monitoring.

Tc-99m-tetrofosmin is a radiopharmaceutical used in medical imaging to evaluate myocardial perfusion. It is commonly used in stress myocardial scans to diagnose coronary artery disease.

The medication is administered intravenously, and images are obtained using a gamma camera. It is important for patients to follow the doctor's instructions before and after the procedure.

Patients should be aware of potential adverse reactions, such as allergic reactions or discomfort at the injection site. It is important to inform the doctor of any unusual symptoms.

Side effects are rare but may include allergic reactions, nausea, or dizziness. Patients should be informed of these risks before the procedure.

General data about MYOVIEW 230mcg

  • Substance: Tc - tetrofosmin
  • Date of latest medicines list: 01-11-2022
  • Product code: W65923002
  • Concentration: 230mcg
  • Pharmaceutical form: kit for radiopharmaceutical preparations
  • Quantity: 5
  • Product type: Original
  • Prescription status: P-RF - Medicines dispensed with a medical prescription that is retained by the pharmacy and cannot be renewed.

Marketing authorisation

  • Manufacturer: GE HEALTHCARE AS - NORVEGIA
  • Holder: GE HEALTHCARE AS - NORVEGIA
  • Number: 9655/2017/02
  • Shelf life: 35 weeks-after packaging for sale;after reconstituting the solution-12h

Pharmaceutical forms available for Tc - tetrofosmin

Concentrations available for Tc - tetrofosmin

  • 0.23mg
  • 230mcg
  • 230mg